Wockhardt gains 4% on filing for DCGI’s approval for its insulin injection
Source: Business Standard 2 min read Last Updated : Oct 16 2024 | 1:31 PM IST Wockhardt shares rose 4.3 per cent on Wednesday and registered an intraday high of Rs 1127.25 per share. The pharma company’s stock gained after it filed for approval for its fast-acting insulin analog, Aspart injection, with India’s drugs…
